Tenax Therapeutics (TENX) Share-based Compensation (2010 - 2026)
Tenax Therapeutics recorded quarterly Share-based Compensation of $2.8 million in Q1 2026, down 40.88% quarter-over-quarter from $4.8 million in Q4 2025, and down 31.48% year-over-year from $4.1 million in Q1 2025.
Tenax Therapeutics' Share-based Compensation history runs 14 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Share-based Compensation fell 31.48% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $17.6 million (up 252.34% YoY), while the FY2025 annual figure was $18.8 million, up 1780.0% from the prior year.
- Share-based Compensation came in at $2.8 million for Q1 2026 at Tenax Therapeutics, down from $4.8 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $5.5 million in Q3 2025 to a low of $9000.0 in Q3 2024.
- A 3-year average of $2.5 million and a median of $2.8 million in 2026 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation surged 61011.11% in 2025 and tumbled 31.48% in 2026, its largest moves.
- Tenax Therapeutics' Share-based Compensation stood at $845000.0 in 2024, then soared by 468.05% to $4.8 million in 2025, then slumped by 40.88% to $2.8 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $2.8 million, $4.8 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | 2.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.84 Mn |
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | 4.50 Mn |
| Jun 30, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Dec 31, 2024 | 845,000.00 |
| Dec 31, 2024 | 845,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Sep 30, 2020 | 25,000.00 |
| Sep 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 25,000.00 |
| Mar 31, 2020 | 25,000.00 |
| Mar 31, 2020 | 25,000.00 |
| Dec 31, 2019 | 33,333.00 |
| Dec 31, 2019 | 33,333.00 |
| Sep 30, 2019 | 24,486.00 |
| Sep 30, 2019 | 24,486.00 |
| Jun 30, 2019 | 25,658.00 |
| Jun 30, 2019 | 25,658.00 |
| Dec 31, 2018 | 114,812.00 |
| Dec 31, 2018 | 114,812.00 |
| Sep 30, 2018 | 62,564.00 |
| Sep 30, 2018 | 62,564.00 |
| Jun 30, 2018 | 29,731.00 |
| Jun 30, 2018 | 29,731.00 |
| Mar 31, 2018 | 100,362.00 |
| Mar 31, 2018 | 100,362.00 |
| Dec 31, 2017 | -79,525.00 |
| Dec 31, 2017 | -79,525.00 |
| Jun 30, 2017 | 79,525.00 |
| Jun 30, 2017 | 79,525.00 |
| Dec 31, 2016 | 204.00 |
| Dec 31, 2016 | 204.00 |
| Sep 30, 2016 | 285.00 |
| Sep 30, 2016 | 285.00 |
| Jun 30, 2016 | 260.00 |
| Jun 30, 2016 | 260.00 |
| Mar 31, 2016 | 313.00 |
| Mar 31, 2016 | 313.00 |
| Dec 31, 2015 | 703.00 |
| Dec 31, 2015 | 703.00 |
| Sep 30, 2015 | 268.00 |
| Sep 30, 2015 | 268.00 |
| Jun 30, 2015 | -13,919.00 |
| Jun 30, 2015 | -13,919.00 |
| Jul 31, 2014 | 14,840.00 |
| Jul 31, 2014 | 14,840.00 |
| Apr 30, 2014 | 397,958.00 |
| Apr 30, 2014 | 397,958.00 |
| Jan 31, 2014 | 173,325.00 |
| Jan 31, 2014 | 173,325.00 |
| Oct 31, 2013 | 66,916.00 |
| Oct 31, 2013 | 66,916.00 |
| Jul 31, 2013 | 13,261.00 |
| Jul 31, 2013 | 13,261.00 |
| Apr 30, 2013 | 185,264.00 |
| Apr 30, 2013 | 185,264.00 |
| Oct 31, 2012 | -75,405.00 |
| Oct 31, 2012 | -75,405.00 |
| Jul 31, 2012 | 75,405.00 |
| Jul 31, 2012 | 75,405.00 |
| Apr 30, 2012 | 21,335.00 |
| Apr 30, 2012 | 21,335.00 |
| Jan 31, 2012 | 54,852.00 |
| Jan 31, 2012 | 54,852.00 |
| Oct 31, 2011 | 26,102.00 |
| Oct 31, 2011 | 26,102.00 |
| Jul 31, 2011 | 25,236.00 |
| Jul 31, 2011 | 25,236.00 |
| Jan 31, 2011 | -53,250.00 |
| Jan 31, 2011 | -53,250.00 |
| Oct 31, 2010 | 53,250.00 |
| Oct 31, 2010 | 53,250.00 |